MAOB and Parkinson disease: Statements 5.1–5.8 (Fig. 5): the totality of the Panelists agreed with the statement that safinamide is safe as add-on therapy for symptomatic PD treatment and that its reversible inhibitory effect of MAO-B represents an advantage in clinical practice.